Resurfacing some of our #raredisease insights in preparation for #WODC. Check out our recent case study, "Mid-size Pharma Accelerates Early Clinical Trial Engagement Of Patients With A Rare Neurological Disease": https://lnkd.in/ehNSU__f #rarediseases #orphandrug
